DeepMatter Group PLC DeepMatter signs multi-year license agreement (1014E)
26 Oktober 2022 - 8:00AM
UK Regulatory
TIDMDMTR
RNS Number : 1014E
DeepMatter Group PLC
26 October 2022
26 October 2022
DeepMatter signs multi-year license agreement with the Life
Science business sector of Merck
DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the
digital chemistry data and software company, has signed a multiyear
database license agreement with Merck, a leading science and
technology company, operating across Healthcare, Life Science and
Electronics.
Pursuant to the agreement, DeepMatter will licence to the Life
Science business sector of Merck certain proprietary data for
machine learning-based applications. The terms of the agreement
were not disclosed.
"We are delighted to announce an important licensing agreement
with Merck, one of the leading companies using digitalisation in
healthcare and life sciences to deliver our vision to provide the
data that enables all medicines to be made in the best possible
way," said Mark Warne, CEO of DeepMatter.
Merck and Deepmatter will also explore ways to identify,
acquire, generate and structure sets of chemical reaction data that
can be used to enable scientists to develop new molecules faster
and more efficiently which could encompass use of DeepMatter's
SmartChemistry(R) capabilities.
For more information contact
DeepMatter Group Plc
Mark Warne, Chief Executive Officer 0141 548 8156
Fraser Benson, Chief Financial Officer
Canaccord Genuity Limited (Nominated Adviser and Broker)
Bobbie Hilliam 020 7523 8000
Meare Consulting
Adrian Duffield 07990 858548
About DeepMatter Group plc
DeepMatter's SmartChemistry(R) platform enables scientists
across a range of industries, including pharma, biotech,
agri-science, scientific publishers and contract research
organisations (CROs), to easily capture, access and exploit the
vast amounts of data created in chemical reactions.
DeepMatter integrates its proprietary chemistry data and
proprietary software to significantly improve productivity,
efficiency, discovery, safety and sustainability of chemical
reactions for its customers.
DeepMatter's SmartChemistry(R) platform capitalises on the
combination of its cloud technology, low cost-sensors, connectivity
to laboratory hardware and high-performance computing trends such
as artificial intelligence (AI).
Visit: www.deepmatter.io and follow @deepmattergroup
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRFELLLLBLEFBL
(END) Dow Jones Newswires
October 26, 2022 02:00 ET (06:00 GMT)
Deepmatter (LSE:DMTR)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Deepmatter (LSE:DMTR)
Historical Stock Chart
Von Dez 2023 bis Dez 2024